Navidea Biopharmaceuticals, Inc - stock earnings
NAVB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.3 million USD | ? USD |
| 2023Q2 | 6.0 million USD | ? USD |
| 2023Q1 | -793486 USD | ? USD |
| 2022Q4 | -5.5 million USD | 610 USD |
| 2022Q3 | -6.5 million USD | 7516 USD |
| 2022Q2 | -3.1 million USD | 6519 USD |
| 2022Q1 | -3.0 million USD | ? USD |
| 2021Q4 | -3.7 million USD | 50348 USD |
| 2021Q3 | -2.4 million USD | 96382 USD |
| 2021Q2 | -2.7 million USD | 261046 USD |
| 2021Q1 | -3.0 million USD | 123737 USD |
| 2020Q4 | -2.8 million USD | 219251 USD |
| 2020Q3 | -2.9 million USD | 6773 USD |
| 2020Q2 | -2.3 million USD | 8920 USD |
| 2020Q1 | -2.7 million USD | 15221 USD |
| 2019Q4 | -2.8 million USD | 2680 USD |
| 2019Q3 | -3.1 million USD | 4895 USD |
| 2019Q2 | -2.7 million USD | 15893 USD |
| 2019Q1 | -2.4 million USD | 97558 USD |
| 2018Q4 | -3.2 million USD | 35040 USD |
| 2018Q3 | -3.8 million USD | 22312 USD |
| 2018Q2 | -2.4 million USD | 264374 USD |
| 2018Q1 | -6.7 million USD | 795 USD |
| 2017Q4 | -4.1 million USD | 395139 USD |
| 2017Q3 | -1.4 million USD | 223669 USD |
| 2017Q2 | -5.2 million USD | 611599 USD |
| 2017Q1 | 85.6 million USD | 580030 USD |
| 2016Q4 | -3.9 million USD | 3.4 million USD |
| 2016Q3 | -59377 USD | 8.5 million USD |
| 2016Q2 | -6.7 million USD | 5.4 million USD |
| 2016Q1 | -3.7 million USD | 4.7 million USD |
| 2015Q4 | -2.5 million USD | 4.3 million USD |
| 2015Q3 | -8.1 million USD | 4.0 million USD |
| 2015Q2 | -9.7 million USD | 2.9 million USD |
| 2015Q1 | -7.3 million USD | 2.1 million USD |
| 2014Q4 | -6.9 million USD | 2.2 million USD |
| 2014Q3 | -6.9 million USD | 2.3 million USD |
| 2014Q2 | -10.2 million USD | 1.1 million USD |
| 2014Q1 | -11.7 million USD | 751804 USD |
| 2013Q4 | -13.8 million USD | 534979 USD |
| 2013Q3 | -11.3 million USD | 400374 USD |
| 2013Q2 | -10.3 million USD | 195277 USD |
| 2013Q1 | -7.3 million USD | 6807 USD |
| 2012Q4 | -7.2 million USD | 6807 USD |
| 2012Q3 | -9.1 million USD | 71.9 million USD |
| 2012Q2 | -5.8 million USD | 60000 USD |
| 2012Q1 | -7.0 million USD | 11931 USD |
| 2011Q4 | -7.6 million USD | -6.3 million USD |
| 2011Q3 | 19.8 million USD | 255632 USD |
| 2011Q2 | -2.2 million USD | 3.2 million USD |
| 2011Q1 | -4.4 million USD | 2.8 million USD |
| 2010Q4 | -2.1 million USD | 3.2 million USD |
| 2010Q3 | -2.4 million USD | 2.3 million USD |
| 2010Q2 | -43.1 million USD | 2.5 million USD |
| 2010Q1 | -2.5 million USD | 2.7 million USD |
| 2009Q4 | -293638 USD | 2.4 million USD |
| 2009Q3 | -25.0 million USD | 2.6 million USD |
| 2009Q2 | -15.1 million USD | 1.8 million USD |
| 2009Q1 | 814121 USD | 2.7 million USD |
| 2008Q4 | -1.2 million USD | 2.0 million USD |
| 2008Q3 | -1.9 million USD | 1.8 million USD |
| 2008Q2 | -1.0 million USD | 2.3 million USD |
| 2008Q1 | -1.0 million USD | 1.8 million USD |
| 2007Q4 | -1.9 million USD | 1.9 million USD |
| 2007Q3 | -941778 USD | 2.0 million USD |
| 2007Q2 | -1.1 million USD | 1.5 million USD |
| 2007Q1 | -1.1 million USD | 1.7 million USD |
| 2006Q4 | -1.3 million USD | 1.9 million USD |
| 2006Q3 | -1.7 million USD | 957952 USD |
| 2006Q2 | -861469 USD | 1.4 million USD |
| 2006Q1 | -927602 USD | 1.8 million USD |
| 2005Q4 | -1.3 million USD | 1.4 million USD |
| 2005Q3 | -1.3 million USD | 1.3 million USD |
| 2005Q2 | -1.3 million USD | 1.7 million USD |
| 2005Q1 | -1.0 million USD | 1.5 million USD |
| 2004Q4 | -2.3 million USD | 1.3 million USD |
| 2004Q3 | -238758 USD | 1.7 million USD |
| 2004Q2 | -429873 USD | 1.5 million USD |
| 2004Q1 | -588577 USD | 1.4 million USD |
| 2003Q4 | -581941 USD | 1.9 million USD |
| 2003Q3 | -659114 USD | 1.2 million USD |
| 2003Q2 | -79372 USD | 1.9 million USD |
| 2003Q1 | -478568 USD | 1.5 million USD |
| 2002Q4 | -164698 USD | 1.7 million USD |
| 2002Q3 | -1.1 million USD | 919761 USD |
| 2002Q2 | -871160 USD | 1.3 million USD |
| 2002Q1 | -845125 USD | 1.1 million USD |
| 2001Q4 | -644788 USD | 1.9 million USD |
| 2001Q3 | 401269 USD | 1.8 million USD |
| 2001Q2 | 177384 USD | 2.3 million USD |
| 2001Q1 | 81088 USD | 1.6 million USD |
| 2000Q4 | 723365 USD | 2.8 million USD |
| 2000Q3 | 504090 USD | 2.3 million USD |
| 2000Q2 | 639313 USD | 2.7 million USD |
| 2000Q1 | -26862 USD | 1.9 million USD |
| 1999Q4 | 250000 USD | 4.2 million USD |
| 1999Q3 | -1.7 million USD | 1.4 million USD |
| 1999Q2 | -1.4 million USD | 1.9 million USD |
| 1999Q1 | -1.3 million USD | 1.9 million USD |
| 1998Q4 | -10.0 million USD | 2.0 million USD |
| 1998Q3 | -5.6 million USD | 1.7 million USD |
| 1998Q2 | -5.3 million USD | 1.3 million USD |
| 1998Q1 | -7.1 million USD | 900000 USD |
| 1997Q4 | -5.8 million USD | 1.6 million USD |
| 1997Q3 | -5.4 million USD | 1.3 million USD |
| 1997Q2 | -7.2 million USD | 1.1 million USD |
| 1997Q1 | -8.8 million USD | 571186 USD |
| 1996Q4 | -4.2 million USD | 200000 USD |
| 1996Q3 | -4.2 million USD | 200000 USD |
| 1996Q2 | -4.4 million USD | 200000 USD |
| 1996Q1 | -3.6 million USD | 200000 USD |
| 1995Q4 | -3.3 million USD | 300000 USD |
| 1995Q3 | -2.5 million USD | 100000 USD |
| 1995Q2 | -2.5 million USD | 300000 USD |
| 1995Q1 | -2.5 million USD | 300000 USD |
| 1994Q4 | -2.8 million USD | 400000 USD |
| 1994Q3 | -3.3 million USD | 200000 USD |
| 1994Q2 | -2.0 million USD | 200000 USD |
| 1994Q1 | -2.6 million USD | 100000 USD |
| 1993Q4 | -2.5 million USD | ? USD |
| 1993Q3 | -2.2 million USD | 100000 USD |
| 1993Q2 | -2.0 million USD | 100000 USD |
| 1993Q1 | -1.3 million USD | 100000 USD |
| 1992Q4 | -800000 USD | ? USD |
| 1992Q3 | -900000 USD | 100000 USD |
NAVB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.2 million USD | 610 USD |
| 2022 | -17.2 million USD | 65652 USD |
| 2021 | -11.7 million USD | 531513 USD |
| 2020 | -10.6 million USD | 915013 USD |
| 2019 | -10.9 million USD | 26618 USD |
| 2018 | -16.1 million USD | 322521 USD |
| 2017 | 74.9 million USD | 1.8 million USD |
| 2016 | -14.3 million USD | 22.0 million USD |
| 2015 | -27.6 million USD | 13.2 million USD |
| 2014 | -35.7 million USD | 6.3 million USD |
| 2013 | -42.7 million USD | 1.1 million USD |
| 2012 | -29.2 million USD | 78738 USD |
| 2011 | 5.6 million USD | 597729 USD |
| 2010 | -50.0 million USD | 10.7 million USD |
| 2009 | -39.6 million USD | 9.5 million USD |
| 2008 | -5.2 million USD | 7.9 million USD |
| 2007 | -5.1 million USD | 7.1 million USD |
| 2006 | -4.7 million USD | 6.1 million USD |
| 2005 | -4.9 million USD | 5.9 million USD |
| 2004 | -3.5 million USD | 6.0 million USD |
| 2003 | -1.8 million USD | 6.5 million USD |
| 2002 | -3.0 million USD | 4.9 million USD |
| 2001 | 14953 USD | 7.6 million USD |
| 2000 | 1.8 million USD | 9.7 million USD |
| 1999 | -4.2 million USD | 9.4 million USD |
| 1998 | -28.0 million USD | 5.8 million USD |
| 1997 | -23.2 million USD | 5.1 million USD |
| 1996 | -21.0 million USD | 1.2 million USD |
| 1995 | -10.8 million USD | 1.0 million USD |
| 1994 | -10.8 million USD | 900000 USD |
| 1993 | -8.0 million USD | 100000 USD |
| 1992 | -2.6 million USD | 100000 USD |
NAVB
Price: $0.04
52 week price:
Earnings Per Share: -0.20 USD
P/E Ratio: -0.17
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 89200
Market Capitalization: 4.0 million